Literature DB >> 25337187

Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.

Lizhu Jiang1, Peng Wang2, Lili Chen3, Hongyan Chen3.   

Abstract

Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor rare throughout most of the world but common in Southern China. Forkhead box M1 (FoxM1) transcription factor has been shown to play important role in the development and progression of human cancers. We have previously found that FoxM1 was overexpressed in NPC patients and was associated with development of NPC. However, the exact functional significance of FoxM1 and its inhibitor thiostrepton in NPC is little known. The purpose of this study was to investigate in vitro activity of down-regulation of FoxM1 by thiostrepton or siRNA against NPC cell line. FoxM1 inhibition by thiostrepton or siRNA inhibited proliferation of NPC cells by down-regulation of cyclin D1 and cyclin E1. Transformation ability of NPC cells was suppressed by thiostrepton. FoxM1 inhibition by thiostrepton induced apoptosis of NPC cells by down-regulation of bcl-2, up-regulation of bax and p53, and inducing release of cytochrome c accompanied by activation of caspase-9, cleaved caspase-3 and cleaved PARP. In addition, FoxM1 inhibition by siRNA transfection also down-regulated expression of bcl-2 and up-regulated expression of bax, p53, cleaved caspase-3 and cleaved PARP. Furthermore, FADD and cleaved caspase-8 expression were up-regulated by thiostrepton or FoxM1 siRNA, and expression of cIAP1 and XIAP was inhibited by thiostrepton. At last, FoxM1 inhibition by thiostrepton reduced the expression of HIF-1α and VEGF, and transfection of FoxM1 siRNA decreased VEGF expression but not HIF-1α. Collectively, our finding suggest that FoxM1 inhibition by thiostrepton or siRNA suppresses proliferation, transformation ability, angiogenesis, and induces apoptosis of NPC.

Entities:  

Keywords:  FoxM1; apoptosis; nasopharyngeal carcinoma; oncogene; proliferation; thiostrepton

Mesh:

Substances:

Year:  2014        PMID: 25337187      PMCID: PMC4203158     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

Review 1.  Mitochondria as the central control point of apoptosis.

Authors:  S Desagher; J C Martinou
Journal:  Trends Cell Biol       Date:  2000-09       Impact factor: 20.808

2.  Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.

Authors:  Jerry E Chipuk; Tomomi Kuwana; Lisa Bouchier-Hayes; Nathalie M Droin; Donald D Newmeyer; Martin Schuler; Douglas R Green
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

3.  Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.

Authors:  Daniel T T Chua; Jun Ma; Jonathan S T Sham; Hai-Qiang Mai; Damon T K Choy; Ming-Huang Hong; Tai-Xiang Lu; Hua-Qing Min
Journal:  J Clin Oncol       Date:  2005-01-18       Impact factor: 44.544

4.  Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias.

Authors:  A R Hussain; M Al-Rasheed; P S Manogaran; K A Al-Hussein; L C Platanias; K Al Kuraya; S Uddin
Journal:  Apoptosis       Date:  2006-02       Impact factor: 4.677

5.  Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.

Authors:  S T Cheung; D P Huang; A B Hui; K W Lo; C W Ko; Y S Tsang; N Wong; B M Whitney; J C Lee
Journal:  Int J Cancer       Date:  1999-09-24       Impact factor: 7.396

6.  Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.

Authors:  Tanya V Kalin; I-Ching Wang; Timothy J Ackerson; Michael L Major; Carol J Detrisac; Vladimir V Kalinichenko; Alexander Lyubimov; Robert H Costa
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

7.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

8.  The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.

Authors:  Limin Xia; Ping Mo; Wenjie Huang; Lin Zhang; Ying Wang; Hongwu Zhu; Dean Tian; Jian Liu; Zhangqian Chen; Yongguo Zhang; Zheng Chen; Hao Hu; Daiming Fan; Yongzhan Nie; Kaichun Wu
Journal:  Carcinogenesis       Date:  2012-07-25       Impact factor: 4.944

Review 9.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer.

Authors:  E C LaCasse; S Baird; R G Korneluk; A E MacKenzie
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

10.  Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Authors:  E A Slee; M T Harte; R M Kluck; B B Wolf; C A Casiano; D D Newmeyer; H G Wang; J C Reed; D W Nicholson; E S Alnemri; D R Green; S J Martin
Journal:  J Cell Biol       Date:  1999-01-25       Impact factor: 10.539

View more
  18 in total

1.  Intranasal wnt3a Attenuates Neuronal Apoptosis through Frz1/PIWIL1a/FOXM1 Pathway in MCAO Rats.

Authors:  Nathanael Matei; Justin Camara; Devin McBride; Richard Camara; Ningbo Xu; Jiping Tang; John H Zhang
Journal:  J Neurosci       Date:  2018-06-28       Impact factor: 6.167

2.  Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells.

Authors:  Xinping Yang; Yuanyuan Shi; Jingzhe Yan; Haitao Fan
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

3.  A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.

Authors:  Yen-Bin Hsu; Ming-Chin Lan; Yu-Lun Kuo; Chi-Ying F Huang; Ming-Ying Lan
Journal:  Invest New Drugs       Date:  2019-04-16       Impact factor: 3.850

4.  Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis.

Authors:  Funda Demirtas Korkmaz; Irem Dogan Turacli; Guldal Esendagli; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

5.  Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

Authors:  Hong Chen; Jingjing Wang; Hong Yang; Dan Chen; Panpan Li
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

6.  Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy.

Authors:  Minzhu Ren; Zhenhua Wang; Guowei Gao; Xiaohua Gu; Liping Wu; Lijun Chen
Journal:  Tumour Biol       Date:  2016-04-05

7.  Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.

Authors:  Lin Li; Biao Fan; Lian-Hai Zhang; Xiao-Fang Xing; Xiao-Jing Cheng; Xiao-Hong Wang; Ting Guo; Hong Du; Xian-Zi Wen; Jia-Fu Ji
Journal:  Tumour Biol       Date:  2016-02-01

8.  FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.

Authors:  Masaaki Kuda; Kenichi Kohashi; Yuichi Yamada; Akira Maekawa; Yoshiaki Kinoshita; Tetsuya Nakatsura; Yukihide Iwamoto; Tomoaki Taguchi; Yoshinao Oda
Journal:  Tumour Biol       Date:  2015-11-09

Review 9.  FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Authors:  Cassie Liu; Carter J Barger; Adam R Karpf
Journal:  Cancers (Basel)       Date:  2021-06-19       Impact factor: 6.639

10.  The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer.

Authors:  Karan Ulhaka; Kanyanatt Kanokwiroon; Mattaka Khongkow; Rassanee Bissanum; Thanaporn Khunpitak; Pasarat Khongkow
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.